Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 14Terminated 8Recruiting 7Active not recruiting 3Withdrawn 2Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 78Colorectal Neoplasms 53Breast Neoplasms 53Neoplasms 40Advanced Solid Tumors 33Prostatic Neoplasms 31Multiple Myeloma 31Neoplasm Metastasis 29Recurrence 28Ovarian Neoplasms 28Lung Neoplasms 28Carcinoma, Hepatocellular 28Pancreatic Neoplasms 26Advanced Solid Tumor 21Small Cell Lung Carcinoma 20Leukemia, Myeloid, Acute 20Melanoma 18Endometrial Neoplasms 18Triple Negative Breast Neoplasms 17Lymphoma, Follicular 15Squamous Cell Carcinoma of Head and Neck 14Stomach Neoplasms 13Lymphoma, B-Cell 13Glioma 13Uterine Cervical Neoplasms 12Head and Neck Neoplasms 12Glioblastoma 12Lymphoma 11Solid Tumor 10Myasthenia Gravis 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Immune System Diseases × Clear all
NCT07192471 2026-04-20

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Kyowa Kirin Co., Ltd.

Phase 1 Not yet recruiting
72 enrolled
DermatologicLymphoid

Immune System Diseases, Lymphoma, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡